Position in EXEL
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$438,979
+$93,286 QoQ
Shares Held
8,068
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#49
of 103 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $5,642,142 across 6 Biotechnology names. EXEL ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
396,354 | $3,470,079 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
11,128 | $882,339 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
907 | $565,550 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
8,068 | $438,979 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
69,500 | $255,065 | |
| 6 | GNLX |
GENELUX Corp
|
10,010 | $30,130 |
All Filings in EXEL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $438,979 | 8,068 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $345,693 | 8,060 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $353,751 | 8,071 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $333,704 | 8,080 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $356,430 | 8,086 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $297,206 | 8,050 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $264,735 | 7,950 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $206,068 | 7,941 | Shares | Sole | 2024-11-12 | |
| 2020-06-30 | $219,618 | 9,251 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||